Ignite Creation Date:
2025-12-24 @ 10:33 PM
Ignite Modification Date:
2026-04-04 @ 4:48 PM
Study NCT ID:
NCT05840835
Status:
UNKNOWN
Last Update Posted:
2023-08-08
First Post:
2023-01-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of IMX-110 in Combination With Tislelizumab in Patients With Advanced Solid Tumors
Sponsor:
Immix Biopharma, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
IMX-110-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None